Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,408 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
A century-and-a-half-old Indiana company is drawing fresh investor attention with a plan to become the world's larges...
New market data indicate AI-driven productivity gains are concentrated among a small group of mega-cap firms, fueling...
Investors are watching SpaceX's potential public listing as markets show cautious appetite for big IPOs. Historical t...
SpaceX is exploring a historic mega-IPO with a razor-thin gross spread. Goldman leads a bid to win the deal at one of...
Artificial intelligence is tightening its grip on personal finance, delivering personalized tools and faster decision...
Struggling to start your financial journey? These affordable financial planning books for beginners offer clear guida...
A 62-year-old with $1.4 million faces a five-year bridge to Social Security. Experts urge planners to treat this as a...
As AI demand reshapes silicon supply, the taiwan semi price prediction for 2026–2030 points to upside but with clear ...
When work gets intense, money decisions get louder. This article breaks down how intensity at work affects your budge...
ICE joins Anthropic’s Project Glasswing to deploy Claude Mythos Preview across its markets, aiming to identify vulner...
A high-profile tribute spotlights the ongoing income from music credits and the importance of estate planning for art...